Doctors and Scientists Take a Bigger Share of New Seats Through 314 Action

Four of this cycle's new officeholders share a background that has become less common in politics: Michigan's Abdul El-Sayed, South Carolina's Annie Andrews, Ohio's Amy Acton and North Carolina's Jamie Ager are each a doctor or a scientist. They also share a backer. All four received support from 314 Action Fund, a political action committee that recruits and funds candidates with science training. The pattern isn't new, but the size of it this year is what's getting attention.

What the PAC spent and where the money went

According to founder Shaughnessy Naughton, a chemist who started 314 Action after losing her own congressional bid in 2016, the PAC spent above $30 million this cycle on donations and direct support, including fundraising for specific races. Two of the largest single commitments went to South Carolina and Ohio. Andrews, a pediatrician, received $3.6 million in the fight over the South Carolina seat that had belonged to Lindsey Graham. Acton, a physician, got roughly $3 million for her Ohio governor race, which was among the most closely watched contests on the map.

Naughton's argument for the spending is straightforward. "We really benefit by having those data-driven, fact-based decisionmakers actually in a position at the governing table," she says. Her framing treats expertise as a qualification in its own right, not a biography point.

The numbers behind the success rate

The organization says its success rate topped 80 percent for congressional candidates. Fourteen of its 17 House candidates won, and the PAC counts hundreds of successful candidates in lower-profile races. Nine of the winning House contests flipped seats from Republican to Democrat, which makes this more than a story about safe-seat incumbents picking up endorsements.

The flipped-seat winners have diverse backgrounds: an oncology nurse practitioner, a mathematician, a microbiologist, a nuclear engineer and an agricultural scientist. That range matters. Many of these candidates aren't lab-coat stereotypes running on a single issue. They're bringing technical credentials into districts that had no reason to expect them. Naughton's summary is that the cycle "did turn out to be a health care" story, and the data gives her some support.

Not new, but arriving in one wave

Richard Frank, who directs the Center on Health Policy at Brookings, points out that health care workers and scientists have always held seats in Congress. The difference is concentration. "What is unusual," he says, "is just how many came in one wave." He ties the surge to hostility toward medical and technical expertise from the Trump administration. "Science has been under attack," Frank says. "It's not surprising that scientists have recognized that, and some of them went out and ran for Congress."

Historian Kristoffer Shields, who runs Rutgers University's Eagleton Institute of Politics, sees more than one cause. Federal cuts that defunded laboratories and scientific research are part of it. He also points to the pandemic, when many health care workers began to see how political decisions shaped public health outcomes. That experience gave a lot of people a reason to move from the clinic or the lab into a campaign office, and it's hard to measure how many made that jump because of a single event.

Here's the thing: these explanations overlap. A researcher who lost funding, a nurse who lived through 2020 and a doctor frustrated by public health messaging may all arrive at the same decision for different reasons. That makes the wave harder to dismiss as a single-issue reaction, and harder to predict once the immediate triggers fade.

Public health as the campaign message

El-Sayed made public health the center of his pitch. Earlier this year he told WIRED that the cyclospora outbreak that sickened Americans over the summer likely traced back to the Trump administration's choices. "We DOGE'd our whole service that keeps the lettuce safe," he said, referring to mass layoffs at the Food and Drug Administration directed through the Department of Government Efficiency. The causal claim is his own, but it shows how these candidates connect personnel decisions to everyday consumer safety.

That direct style is another asset, Shields suggests. Doctors and scientists tend to communicate plainly, and some of this year's winners lean into it. Andrews has called Health and Human Services Secretary Robert F. Kennedy Jr. her "archnemesis" and promised to hold him accountable. Clark, the incoming representative from Georgia and a microbiologist, told The Guardian that she was "appalled seeing infectious diseases spreading through our communities that we had once declared eradicated."

314 Action has been equally direct about its target. Naughton says the PAC views rebuking Kennedy's agenda as a core goal, and that its messaging is designed to be forthright about opposition to the administration's public health approach. The contrast with other physician-focused groups is deliberate. The American Medical Association's PAC supports doctors in office across parties, while 314 Action focuses specifically on Democratic health and science experts.

Funding scrutiny and the AIPAC question

The PAC's funding history has drawn its own attention. In 2024, its past acceptance of money from groups with ties to the pro-Israel lobbying group AIPAC came under scrutiny. The organization says it no longer accepts AIPAC funding, and it has backed candidates such as El-Sayed, who were openly critical of the Israeli government. For anyone tracking where these new officeholders get their money, that shift is worth watching alongside the headline totals.

What comes next

In 2025, 314 Action launched its Guardians of Public Health initiative to recruit health care professionals into public office. Naughton explains the logic directly: the group wanted to speak to doctors and nurses and tell them to step up, "because we have a madman running" the department overseeing health and human services. The PAC begins its next recruitment round later this month.

The open questions are practical. Will these new members work across committees on shared health and research funding, or will they scatter across unrelated assignments? Can a PAC built around an anti-Kennedy message hold its appeal once the person at its center changes? And does a cohort defined by its expertise keep its coherence once it's inside the institution? The answers will show whether this wave is a set of individual races or the start of a durable bloc.